Suchergebnisse - "Oluwole, Olalekan O"

PubPharm (65)

31

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia : A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research

enthalten in: Transplantation and cellular therapy | 2022

von Murthy, H. | Ahn, K. | Estrada-Merly, N. | +58

32

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

enthalten in: The New England journal of medicine | 2022

von Locke, F. | Miklos, D. | Jacobson, C. | +129

CommentIn: N Engl J Med. 2022 Feb 17;386(7):692-696. - PMID 34904797

33

Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the US

enthalten in: Journal of medical economics | 2022

von Oluwole, O. | Liu, R. | Diakite, I. | +5

34

Chimeric antigen receptor T-cell therapy : Challenges and framework of outpatient administration

enthalten in: EJHaem | 2022

von Gatwood, K. | Dholaria, B. | Lucena, M. | +3

35

Chimeric antigen receptor-T cell therapies : The changing landscape

enthalten in: EJHaem | 2022

von Sengsayadeth, S. | Dholaria, B. | Savani, B. | +1

36

Role of bridging therapy during chimeric antigen receptor T cell therapy

enthalten in: EJHaem | 2022

von Bhaskar, S. | Dholaria, B. | Sengsayadeth, S. | +2

37

Chronic myeloid leukemia with pure erythroid leukemia blast crisis

enthalten in: Leukemia & lymphoma | 2022

von Jacobs, J. | Ramaswamy, R. | States, V. | +4

38

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5) : a single-arm, multicentre, phase 2 trial

enthalten in: The Lancet. Oncology | 2022

von Jacobson, C. | Chavez, J. | Sehgal, A. | +20

CommentIn: Lancet Oncol. 2022 Jan;23(1):6-8. - PMID 34895488

39

Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools : The Vanderbilt experience

enthalten in: British Journal of Haematology | 2022

von Dholaria, B. | Mehraban, N. | Baer, B. | +7

40

Chimeric antigen receptor T‐cell therapy : Challenges and framework of outpatient administration

enthalten in: eJHaem | 2022

von Gatwood, K. | Dholaria, B. | Lucena, M. | +3